https://www.psychiatrist.com/news/study-intravenous-ketamine-vs-intranasal-esketamine/
0
0
9/12/23 at 1:05pm
Organization
Psychiatrist.com
30 words
0
Comments
A study finds intravenous ketamine as effective but more cost-efficient than FDA-approved esketamine in treatment-resistant depression.
You are the first to view
Create an account
or login to join the discussion